Epidemiological survey on the benefit of neuraminidase inhibitors on severe acute respiratory syndrome due to COVID-19
DOI:
https://doi.org/10.17058/reci.v13i1.17973Keywords:
SARS, Zanamivir, Oseltamivir, COVID-19Abstract
Background and objectives: The COVID-19 pandemic and its consequent severe acute respiratory syndrome (SARS) have taken the lives of millions since 2020. The use of neuraminidase inhibitors is a promising alternative in treating this disease, with several studies on off-label use being conducted since the beginning of the pandemic, but none of them have a large sample size and analyze multiple risk factors. The purpose of this article is to identify possible associations between various factors and risk of hospitalization, need for ventilation and death, as well as the influence of the prescription of Zanamivir and Oseltamivir on these same indicators. Methods: In this transversal study, approximately 900,000 medical records from all regions of Brazil were collected from the Ministry of Health database, and after that, proper statistical analysis of the variables was performed. Results: Hospitalization was associated with gender, ethnicity, education, local urbanization, State, and its percentage of elderly, as well as the climate. The prescription of Zanamivir and Oseltamivir was associated with higher incidence of symptoms, lower hospitalization and death rate, and lower need for invasive and non-invasive ventilation. Medical records from146,160 patients were excluded due to SARS not caused by COVID-19. Conclusion: From this data, it is possible to draw a risk profile for hospitalization by SARS and consider the use of Zanamivir and Oseltamivir as a treatment for these patients.
Downloads
References
Rabaan AA, Al-Ahmed SH, Haque S, et al. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez Med. 2020;28(2):174–84.
Platto S, Wang Y, Zhou J, et al. History of the COVID-19 pandemic: Origin, explosion, worldwide spreading. Biochem Biophys Res Commun. 2021;538:14–23. http://dx.doi.org/10.1016/j.bbrc.2020.10.087
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet Lond Engl. 2022;399(10334):1513–36. http://dx.doi.org/10.1016/S0140-6736(21)02796-3
Diamond M, Peniston HL, Sanghavi D, et al. Acute Respiratory Distress Syndrome. Em: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 http://www.ncbi.nlm.nih.gov/books/NBK436002/
Wiener-Kronish JP, Albertine KH, Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest. 1991;88(3):864–75. http://dx.doi.org/10.1172/JCI115388
Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163(6):1376–83. http://dx.doi.org/10.1164/ajrccm.163.6.2004035
Gattinoni L, Pesenti A. The concept of “baby lung”. Intensive Care Med. 2005;31(6):776–84. http://dx.doi.org/10.1007/s00134-005-2627-z
Dantzker DR, Brook CJ, Dehart P, et al. Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis. 1979;120(5):1039–52. http://dx.doi.org/10.1164/arrd.1979.120.5.1039
Cascella M, Rajnik M, Aleem A, et al. Features, Evaluation, and Treatment of Coronavirus (COVID-19). Em: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 http://www.ncbi.nlm.nih.gov/books/NBK554776/
Liu, J., Zhang, S., Wu, Z. et al. Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study. Ann. Intensive Care 10, 99 (2020). https://doi.org/10.1186/s13613-020-00706-3
Tan Q, Duan L, Ma Y, et al. Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study. Bioorg Chem. 2020;104:104257. https://dx.doi.org/10.1016/j.bioorg.2020.104257
de Oliveira Formiga R, Amaral FC, Souza CF, et al. Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19 [published online ahead of print, 2022 Dec 16]. Br J Pharmacol. 2022;10.1111/bph.16013. https://dx.doi.org/10.1111/bph.16013
Ministério da Saúde (BR). OpenDataSUS: SRAG 2021 a 2023 [Internet]. Brasília: Ministério da Saúde; [atualizado em 2023 mar 2; citado em 2023 mar 2]. Disponível em: https://opendatasus.saude.gov.br/dataset/srag-2021-a-2023
Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 — Final Report. N Engl J Med. 2020;383(19):1813–26. http://dx.doi.org/10.1056/NEJMoa2007764
Niquini RP, Lana RM, Pacheco AG, et al. SRAG por COVID-19 no Brasil: descrição e comparação de características demográficas e comorbidades com SRAG por influenza e com a população geral. Cad Saúde Pública. 2020;36(7):e00149420. http://dx.doi.org/10.1590/0102-311x00149420
Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: are males more vulnerable? Biol Sex Differ. 2020;11:53. http://dx.doi.org/10.1186/s13293-020-00330-7
Prinelli F, Trevisan C, Noale M, et al. Sex- and gender-related differences linked to SARS-CoV-2 infection among the participants in the web-based EPICOVID19 survey: the hormonal hypothesis. Maturitas. 2022;158:61–9. http://dx.doi.org/10.1016/j.maturitas.2021.11.015
Retrato das Desigualdades de Gênero e Raça - Ipea https://www.ipea.gov.br/retrato/indicadores_pobreza_distribuicao_desigualdade_renda.html
Whittaker C, Walker PGT, Alhaffar M, et al. Under-reporting of deaths limits our understanding of true burden of covid-19. BMJ. 2021;375:n2239. http://dx.doi.org/10.1136/bmj.n2239
Aikens N, Barbarin O. Socioeconomic Differences in Reading Trajectories: The Contribution of Family, Neighborhood, and School Contexts. J Educ Psychol. 2008;100:235–51. http://dx.doi.org/10.1037/0022-0663.100.2.235
Estimativas da população residente para os municípios e para as unidades da federação | IBGE https://www.ibge.gov.br/estatisticas/sociais/populacao/9103-estimativas-de-populacao.html?=&t=resultados
Teller J. Urban density and Covid-19: towards an adaptive approach. Build Cities. 2021;2(1):150–65. http://dx.doi.org/10.5334/bc.89
Pirâmides Etárias e Envelhecimento da População - Atlas Socioeconômico do Rio Grande do Sul https://atlassocioeconomico.rs.gov.br/piramides-etarias-e-envelhecimento-da-populacao
Maciel EL, Jabor P, Goncalves Júnior E, et al. Fatores associados ao óbito hospitalar por COVID-19 no Espírito Santo, 2020. Epidemiol E Serviços Saúde. 2020 http://scielo.iec.gov.br/scielo.php?script=sci_abstract&pid=S1679-49742020000400026&lng=pt&nrm=iso&tlng=pt http://dx.doi.org/10.1590/s1679-49742020000400022
Cartilha do Uso Racional do medicamento fosfato de oseltamivir e zanamivir para os casos de infecção pelo vírus da Influenza — Português (Brasil) https://www.gov.br/saude/pt-br/composicao/sctie/daf/publicacoes/2022/2022-0015-cartilha-uso-racional-de-medicamento-fosfato-de-oseltamivir-e-zanamivir.pdf/view
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Thamara Graziela Flores, Carlos Fernando Antunes Gonçalves, Fernanda Barbisan, Ivana Beatrice Manica da Cruz, Melissa Agostini Lampert, Nathália Cardoso de Afonso Bonotto, Isis Niero Volpato
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.
